Hôpital Croix Rousse
Lyon, Rhone, 69004, France
NCT Number: NCT06391476
Advancements in perinatal care have significantly improved the survival of extremely premature infants, establishing a viability threshold below 25 weeks' gestational age (GA). However, management at the limit of viability poses ethical and decision-making problems for health-care professionals. They grapple with the delicate balance between potential survival and long-term disabilities.
These decisions, as well as the information given to families, are based on knowledge of the prognosis as assessed by national and international epidemiological studies. Healthcare professionals rely on population-based estimations but face discrepancies in predicting outcomes because there are significant variation depending on perinatal center and country where infants are hospitalized. In the large French epidemiological study, 9,6% of livebirths included were born at 22-25 wks and only 38% survived.
In the neonatology department of the croix rousse, these infants have been actively cared for for many years, which has allowed the development of specific skills that are essential for the proper management of these very high-risk patients. Furthermore, EPIPAGE 2 included data from centers where perinatal management was probably not very active at these extreme ages. It results in worse neonatal outcomes as evaluated at the national level than outcomes data evaluated at the neonatal intensive care unit of Croix-Rousse hospital. Using data from EPIPAGE 2 study for clinical decision could lead to avoid active care at the for some infants at the limit of viability It is needed to obtain complete evaluation of neonatal outcomes of infants hospitalized at the Croix-Rousse hospital, so that clinicians may rely on actualized data related to the practices in their perinatal center. It is also needed to compare outcomes with data from large national and international cohorts, to identify and quantify differences. Data about later neurodevelopment outcomes, at 2 years, are also needed as it can taken in consideration in decision-making process.
Looking for future studies?
Notify Me22 week–25 week
All sexes
Observational
Lyon, Rhone, 69004, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 24 months corrected age
Proportion of deaths in a cohort of infants born between 22 - 25 weeks gestational age
Hospices Civils de Lyon
Other
Morbi-mortality and Development at 2 Years in Infants Born at the Limit of Viability
Acronym: PRELIVIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05711927
Behavior, Communication
New York, United States
View Trial DetailsNCT05436925
Glucose Metabolism Disorders, Hyperglycemia
Minneapolis, Minnesota, United States
View Trial DetailsNCT05949788
Anemia, Hematologic Diseases
Shenzhen, Guangdong, China
View Trial DetailsNCT06076460
Enteral Feeding Intolerance, Very Preterm Maturity of Infant
New Delhi, National Capital Territory of Delhi, India
View Trial Details